Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
Recruiting now · Not applicable · Has a placebo group
Conditions studied: PARKINSON DISEASE (Disorder), Parkinson's Disease (PD)
In brief
This study is designed to better understand the mechanisms contributing to impaired activation of leg muscles in people with Parkinson's disease (PD) and to test if stimulation of a nerve at the neck can improve muscle activation, walking and balance.
Key facts
- Study ID
- NCT07226284
- Run by
- University of Minnesota
- People needed
- 75
- Starts
- 2026-02-10
- Expected to finish
- 2029-01-01
- Last updated by the study team
- 2026-02-13
Who can join
Age: 21 and older, up to 76. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Diagnosis of idiopathic Parkinson's disease,
- On stable medication for the preceding month and anticipated over the next 3 months,
- Able to ambulate without the use of an assistive device for more than 50 meters.
- Control Cohort:
- Age (± 3 years) and sex distribution matched to the PD cohort,
- Able to ambulate without the use of an assistive device for more than 50 meters.
You may not qualify if…
- Failure to demonstrate capacity to consent (based on UBACC and/or MacArthur-CR),
- History of significant neurological disorder (besides PD in the PD group),
- History of stroke, traumatic brain injury, intracranial aneurysm, intracranial hemorrhage, brain tumor or atypical parkinsonian disorder,
- Severe orthopedic or other related musculoskeletal pathology that has significant adverse effects on gait,
- Women who are pregnant or may be pregnant,
- Insufficient comprehension of the English language,
- History of substance abuse in past 2 years;
- Additional exclusion criteria for VNS experiment
- Pain at the nVNS treatment site (e.g., dysesthesia, neuralgia, cervicalgia);
- Lesion (including lymphadenopathy), previous surgery (including carotid endarterectomy or vascular neck surgery) or abnormal anatomy at the stimulation site (open wound, rash, infection, swelling, cut, sore, drug patch, surgical scar[s]);
- Known or suspected severe atherosclerotic cardiovascular disease, severe carotid artery disease (e.g., bruits or history of TIA or stroke), congestive heart failure, known severe coronary artery disease or prior myocardial infarction;
- Abnormal baseline electrocardiogram (ECG) within the last year (e.g., second or third-degree heart block, prolonged QT interval, atrial fibrillation, atrial flutter, history of ventricular tachycardia or ventricular fibrillation);
- Recent history of uncontrolled high blood pressure, bradycardia, tachycardia, or know recent history orthostatic hypotension;
- Previous unilateral or bilateral vagotomy;
- Implanted metal cervical spine hardware, other metallic implants or implantable medical devices such as deep brain stimulator, hearing aid implant, pacemaker, implanted cardioverter defibrillator, cranial aneurysm and/or cranial aneurysm clips, history of facial/orbital/metallic fragments, implanted electronic device, neurostimulator, valve replacements/stents, metallic implants/prostheses) near the stimulation site such as a bone plate or bone screw;
- History of syncope or seizures (within the last 2 years);
Where it is running
- Movement Disorders Laboratory — Minneapolis, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.